Effects of prostadyn sabale capsules on chronic prostatitis.
- Author:
Tianpeng WU
1
;
Xiaobin ZHANG
;
Rongyang WU
;
Xiuheng LIU
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Capsules; Chronic Disease; Humans; Male; Middle Aged; Phytotherapy; Prostatitis; drug therapy; Serenoa
- From: National Journal of Andrology 2004;10(5):337-339
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the effects of prostadyn sabale capsules on chronic prostatitis (CP).
METHODSOne hundred and twenty-five CP cases were divided into three categories according to National Institutes of Health (NIH) concensus definition and classification of CP:31 of category II. 75 of category IIIA and 19 of category IIIB. All the cases were treated with prostadyn sabale capsules at the dosage of 320 mg twice a day. NIH chronic prostatitis symptom index (NIH-CPSI), routine examination and culture of expressed prostatic secretions (EPS) were prospectively evaluated before and after treatment.
RESULTSThe cure rates of category II, category IIIA and category IIIB were 25.8%, 16.0%, and 21.1% respectively, the general cure rate being 19.2%. The alleviation rate was 63.5% and the total effectivity rate was 82.7%. No side effects were observed.
CONCLUSIONSProstadyn sabale capsules have good effects on CP.
